RxSight, Inc. - Common Stock (OQ:RXST)

Business Focus: N/A

Get the company report for the most recent outlook updated daily

May 13, 2024 04:05 pm ET

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it has closed its underwritten public offering of 2,053,571 shares...

May 08, 2024 09:15 pm ET

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

(NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced today that it has priced its underwritten public offering. RxSight...

May 08, 2024 04:05 pm ET

RxSight, Inc. Announces Proposed Public Offering of Common Stock

RxSight, Inc., (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced today that it intends to offer and sell, subject to market and other...

May 06, 2024 04:05 pm ET

RxSight, Inc. Reports First Quarter 2024 Financial Results

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended March 31, 2024. Key...

May 01, 2024 04:05 pm ET

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference. RxSight’s...

Apr 22, 2024 04:05 pm ET

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter of 2024...

Apr 04, 2024 04:05 pm ET

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the commercial launch of its newest Light Adjustable Lens, the LAL+....

Mar 27, 2024 04:05 pm ET

RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference

(NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 23rd Annual Needham Virtual...

Feb 29, 2024 07:05 pm ET

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

Feb 28, 2024 04:05 pm ET

RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months and full year ended December 31, 2023....

Feb 14, 2024 04:05 pm ET

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

(NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and full...

Jan 07, 2024 10:00 am ET

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter...

Dec 27, 2023 04:05 pm ET

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Nov 09, 2023 04:05 pm ET

RxSight, Inc. Reports Third Quarter 2023 Financial Results

Nov 02, 2023 09:00 am ET

RxSight, Inc. Educational and Product Announcements for AAO 2023

November 2, 2023 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced educational opportunities and product updates at the American...

Oct 26, 2023 04:05 pm ET

RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023

Aug 23, 2023 04:05 pm ET

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

Aug 07, 2023 04:05 pm ET

RxSight, Inc. Reports Second Quarter 2023 Financial Results

Jul 25, 2023 04:05 pm ET

RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023

May 09, 2023 04:05 pm ET

RxSight, Inc. Reports First Quarter 2023 Financial Results

Apr 26, 2023 04:05 pm ET

RxSight, Inc. to Present at the Bank of America Healthcare Conference

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare...

Apr 25, 2023 04:05 pm ET

RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023

Apr 24, 2023 04:05 pm ET

Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that its Light Adjustable Lens™ system will be the subject of...

Apr 05, 2023 04:05 pm ET

RxSight, Inc. to Present at the Needham Healthcare Conference

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Needham Healthcare Conference....

Mar 06, 2023 04:05 pm ET

RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 28, 2023 04:05 pm ET

RxSight, Inc. to Present at the Oppenheimer Healthcare Conference

RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Oppenheimer Healthcare Conference. RxSight’s...

Feb 21, 2023 04:05 pm ET

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and...

Feb 14, 2023 04:05 pm ET

RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock

RxSight, Inc. (“RxSight®”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that, in connection with its previously announced public offering of common stock (the...

Feb 08, 2023 12:45 am ET

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

(NASDAQ: RXST) – RxSight, Inc. (“RxSight”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it has priced its underwritten public offering. RxSight expects to sell...

Feb 07, 2023 04:05 pm ET

RxSight, Inc. Announces Proposed Public Offering of Common Stock

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it intends to offer and sell, subject to market and other conditions, $40.0 million...

Jan 08, 2023 04:00 pm ET

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter...

Dec 28, 2022 04:05 pm ET

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

(NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s...

Nov 07, 2022 04:05 pm ET

RxSight, Inc. Reports Third Quarter 2022 Financial Results

RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three and nine months ended September 30, 2022. Key Quarterly Highlights:...

Oct 24, 2022 04:05 pm ET

RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022

(NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the third quarter 2022 after the market close on...

Aug 24, 2022 04:05 pm ET

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

Aug 08, 2022 04:10 pm ET

RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it has filed a $200 million shelf registration statement on Form S-3 with the...

Aug 08, 2022 04:05 pm ET

RxSight, Inc. Reports Second Quarter 2022 Financial Results

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three and six months ended June 30, 2022. Key Quarterly...

Jul 25, 2022 04:05 pm ET

RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the second quarter 2022 after the market close...

May 05, 2022 04:05 pm ET

RxSight, Inc. Reports First Quarter 2022 Financial Results

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months ended March 31, 2022. Key Quarterly Highlights:...

Apr 22, 2022 09:00 am ET

RxSight, Inc. to Present at the Bank of America Healthcare Conference

(NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference. RxSight’s...

Apr 21, 2022 04:05 pm ET

RxSight, Inc. to Report First Quarter 2022 Financial Results on May 5, 2022

(NASDAQ: RXST) – April 21, 2022 – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the first quarter 2022 after...

Apr 19, 2022 04:30 pm ET

Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

(NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that its Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens®...

Mar 28, 2022 04:05 pm ET

RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

(NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Needham Virtual Healthcare Conference. RxSight’s...

Mar 08, 2022 04:05 pm ET

RxSight, Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results

(NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months and fiscal year ended December 31, 2021. Recent...

Mar 01, 2022 08:00 am ET

Inari Medical Appoints Robert Warner to Board of Directors

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the appointment of Mr. Robert Warner to its board of...

Feb 23, 2022 04:10 pm ET

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 8, 2022

Feb 03, 2022 04:05 pm ET

RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference

RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual SVB Leerink Global Healthcare Conference. RxSight’s...

Jan 09, 2022 04:00 pm ET

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

(NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced preliminary unaudited financial and operational results for the fourth quarter and fiscal...

Jan 04, 2022 04:05 pm ET

RxSight, Inc. Appoints Dr. Tamara R. Fountain, M.D. and Shweta Singh Maniar to its Board of Directors

(NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced the appointment of Tamara R. Fountain, M.D. and Shweta Singh Maniar to its Board of...

Dec 28, 2021 04:05 pm ET

RxSight to Present at the J.P. Morgan Healthcare Conference

RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual J.P. Morgan Healthcare Conference. RxSight®...

Nov 18, 2021 04:05 pm ET

RxSight to Participate in the Ophthalmology Day at BTIG

Nov 10, 2021 04:05 pm ET

RxSight Reports Third Quarter 2021 Financial Results

Oct 27, 2021 04:05 pm ET

RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021

RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the third quarter of 2021 after the market close on Wednesday, November 10, 2021. The company’s management will discuss the results...

Sep 09, 2021 04:05 pm ET

RxSight Reports Second Quarter 2021 Financial Results

RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months ended June 30, 2021. Recent Highlights Achieved second...

Sep 01, 2021 08:00 am ET

RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021

RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company, today announced an updated date for reporting second quarter 2021 financial results. In observance of the Rosh Hashanah holiday, the company will now report after the market close...

Aug 31, 2021 08:00 am ET

RxSight to Participate in the Wells Fargo Healthcare Conference

RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, today announced plans to participate in the upcoming virtual Wells Fargo Healthcare Conference. RxSight’s management is scheduled to present Friday, September 10, 2021, at 12:00pm...

Aug 24, 2021 04:05 pm ET

RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021

RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company’s management will discuss the results during...

Aug 17, 2021 04:05 pm ET

RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales

(NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly has joined the company as its Vice President of U.S. Sales. In this new position, Mr. Everly will lead the continued development and expansion...

Aug 10, 2021 08:05 pm ET

RxSight Announces Appointments to its Board of Directors

RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective as of the closing of the Company’s initial public offering on August 3, 2021. The three appointments,...

Aug 04, 2021 04:05 pm ET

RxSight, Inc. Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters’ Option to Purchase Additional Shares

RxSight, Inc., an ophthalmic medical device company, today announced the closing of its initial public offering of 7,350,000 shares of common stock on August 3, 2021, as well as the partial exercise of the underwriters’ option to purchase an...

Jul 29, 2021 10:16 pm ET

RxSight, Inc. Announces Pricing of Initial Public Offering

RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common stock at a public offering price of $16.00 per share. The gross proceeds to RxSight® from the offering are...

Ad blocking detected

RxSight, Inc. - Common Stock (OQ:RXST)

Business Focus: N/A